[A study on salivary peptide P-C with special reference to intracellular localization of salivary peptide P-C like immunoreactivity in the human pancreatic B-cells].
In order to clarify the intracellular localization of salivary peptide P-C like immunoreactivity in the human pancreatic B-cells, an immuno-electronmicroscopical study using protein A-gold technique was carried out on the human foetal pancreas. Salivary peptide P-C like immunoreactivity was present in some of insulin secretory granules while insulin like immunoreactivity was found in all insulin secretory granules. The finding suggested that new substance in addition to insulin and its precursor was present in the insulin secretory granules of the human pancreatic B-cells. Furthermore, the finding seemed to explain the previous study that development of salivary peptide'P-C like immunoreactivity in the foetal pancreatic B-cells was immature in compared to that in the human adult pancreatic B-cells. In addition, to examine whether or not, salivary peptide P-C like immunoreactivity in the human pancreatic B-cells is Salivary Protein C, an indirect immunofluorescence technique using three kinds of antisera against salivary peptide P-C, Salivary Protein C and salivary peptide P-B, and using their antigens was undertaken on the adult pancrease. From the results of the study, it was thought that salivary peptide P-C like immunoreactivity in the human pancreas was neither Salivary Protein C itself, nor salivary peptide P-B itself, but was either salivary peptide P-C itself or unknown substance which had the common antigenic determinant with salivary peptide P-C, P-B and Salivary Protein C, since salivary peptide P-C like immunoreactivity in the human pancreas disappeared in the sections in which P-C antisera preincubated with each of salivary peptide P-C, P-B and Salivary Protein C were used as the primary antisera. Thus, although new substance was present in the insulin secretory granules of the human pancreatic B-cells, its pathophysiological role remained to be elucidated.
D003594:Cytoplasmic Granules / Q000032:analysis; D005260:Female; D005333:Fetus / Q000032:analysis; D005455:Fluorescent Antibody Technique; D006801:Humans; D007515:Islets of Langerhans / Q000032:analysis*; D010455:Peptides / Q000032:analysis* / Q000276:immunology; D011247:Pregnancy; D055232:Proline-Rich Protein Domains; D055273:Salivary Proline-Rich Proteins; D012471:Salivary Proteins and Peptides / Q000032:analysis*
D010455:Peptides; D055273:Salivary Proline-Rich Proteins; D012471:Salivary Proteins and Peptides; C524743:salivary peptide P-C